Filana Therapeutics (FLNA) Shares Outstanding (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Shares Outstanding (Entity) of $4.1 million for Q2 2026, down 91.51% year-over-year from $48.3 million in Q2 2025, and up 3.3% quarter-over-quarter from $4.0 million in Q1 2026.
Filana Therapeutics (FLNA) Shares Outstanding (2010 - 2026) Analysis & Trends
Filana Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $4.1 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) fell 91.51% year-over-year to $4.1 million; the TTM figure through Jun 2026 stood at $4.1 million (down 91.51% YoY), while the FY2025 annual figure was $48.3 million, changed 0.22% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $4.1 million, up from $4.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $48.3 million in Q1 2025, with the low at $2.0 million in Q1 2023.
- The 5-year median for Shares Outstanding (Entity) is $42.2 million (2023), against an average of $37.7 million.
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) plunged 94.92% in 2023, then soared 2026.27% in 2024.
- Filana Therapeutics' Shares Outstanding (Entity) stood at $41.7 million in 2022, then climbed by 1.2% to $42.2 million in 2023, then grew by 14.13% to $48.2 million in 2024, then increased by 0.22% to $48.3 million in 2025, then tumbled by 91.51% to $4.1 million in 2026.
- Business Quant data shows FLNA's Shares Outstanding (Entity) at $4.1 million in Q2 2026, $4.0 million in Q1 2026, and $48.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - | 48.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.10 Mn |
| Mar 31, 2026 | 3.97 Mn |
| Dec 31, 2025 | 48.30 Mn |
| Sep 30, 2025 | 48.31 Mn |
| Jun 30, 2025 | 48.31 Mn |
| Mar 31, 2025 | 48.26 Mn |
| Dec 31, 2024 | 46.33 Mn |
| Sep 30, 2024 | 47.98 Mn |
| Jun 30, 2024 | 46.20 Mn |
| Mar 31, 2024 | 43.00 Mn |
| Dec 31, 2023 | 41.93 Mn |
| Sep 30, 2023 | 42.00 Mn |
| Jun 30, 2023 | 41.79 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 40.20 Mn |
| Sep 30, 2022 | 40.05 Mn |
| Jun 30, 2022 | 40.02 Mn |
| Mar 31, 2022 | 39.96 Mn |
| Dec 31, 2021 | 39.41 Mn |
| Sep 30, 2021 | 39.96 Mn |